122 related articles for article (PubMed ID: 27347156)
21. The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo.
Wendel T; Zhen Y; Suo Z; Bruheim S; Wiedlocha A
Exp Cell Res; 2016 Jan; 340(2):220-6. PubMed ID: 26748184
[TBL] [Abstract][Full Text] [Related]
22. Adult T-cell leukemia/lymphoma in Jujuy, north-west Argentina.
Marin O; Hasui K; Remondegui C; Sato E; Aye MM; Takenouchi N; Izumo S; Tajima K
Pathol Int; 2002; 52(5-6):348-57. PubMed ID: 12100517
[TBL] [Abstract][Full Text] [Related]
23. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.
Tsai HJ; Shih NY; Kuo SH; Cheng AL; Lin HY; Chen TY; Chang KC; Lin SF; Chang JS; Chen LT
Leuk Lymphoma; 2015; 56(9):2674-82. PubMed ID: 25535814
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Marutsuka K; Hidaka T; Maeda K; Hatakeyama K; Shiraga T; Goto A; Takamatsu N; Asada Y; Utsunomiya A; Okayama A; Kubuki Y; Shimoda K; Ukai Y; Kurosawa G; Morishita K
Leukemia; 2012 Jun; 26(6):1238-46. PubMed ID: 22289924
[TBL] [Abstract][Full Text] [Related]
25. HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells.
Tao W; Chakraborty SN; Leng X; Ma H; Arlinghaus RB
Genes Cancer; 2015 Jan; 6(1-2):19-29. PubMed ID: 25821558
[TBL] [Abstract][Full Text] [Related]
26. Expression of human T-cell leukaemia virus type I and associated antigens, and interleukin-2 and receptor in lymph nodes of adult T-cell leukaemia/lymphoma.
Ohshima K; Kikuchi M; Kobari S; Shiraki H; Sumiyoshi Y; Yoneda S; Masuda Y; Takeshita M; Kimura N
Virchows Arch; 1994; 425(3):249-58. PubMed ID: 7812510
[TBL] [Abstract][Full Text] [Related]
27. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
28. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma.
Shimakage M; Inoue N; Ohshima K; Kawahara K; Yamamoto N; Oka T; Tambe Y; Yasui K; Matsumoto K; Yutsudo M; Inoue H
Int J Oncol; 2007 Jun; 30(6):1343-8. PubMed ID: 17487354
[TBL] [Abstract][Full Text] [Related]
30. Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer.
Yeramian A; García V; Bergadà L; Domingo M; Santacana M; Valls J; Martinez-Alonso M; Carceller JA; Cussac AL; Dolcet X; Matias-Guiu X
Mol Imaging Biol; 2016 Aug; 18(4):545-56. PubMed ID: 26604096
[TBL] [Abstract][Full Text] [Related]
31. NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo.
Lian J; Lin D; Xie X; Xu Y; Xu L; Meng L; Zhu Y
Onco Targets Ther; 2017; 10():2219-2226. PubMed ID: 28458565
[TBL] [Abstract][Full Text] [Related]
32. Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia/Lymphoma.
Boonnate P; Kariya R; Okada S
Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107239
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma.
Kosovec JE; Zaidi AH; Kelly LA; Rotoloni CL; Vytlacil C; DiCarlo C; Matsui D; Komatsu Y; Boyd NH; Omstead A; Kolano EL; Biederman RW; Finley G; Silverman JF; Landreneau RJ; Jobe BA
Ann Surg; 2016 Aug; 264(2):297-304. PubMed ID: 26445473
[TBL] [Abstract][Full Text] [Related]
34. Adult T-cell leukemia/lymphoma complicated by
Kunimoto M; Inomata M; Chin H; Ito Y; Fujimoto K; Muto Y; Nomura M; Sato K; Sakamoto K; Awano N; Kuse N; Kumasaka T; Takemura T; Izumo T
Respir Med Case Rep; 2023; 42():101807. PubMed ID: 36660069
[TBL] [Abstract][Full Text] [Related]
35. CD4 and CD8 double-negative adult T-cell leukemia/lymphoma with monomorphic cells expressing CD99: a diagnostic challenge in a country non-endemic for human T-cell leukemia virus.
Lin TH; Wu HC; Hsieh YC; Tseng CE; Ichinohasama R; Chuang SS
Pathol Int; 2013 Feb; 63(2):132-7. PubMed ID: 23464972
[TBL] [Abstract][Full Text] [Related]
36. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
[TBL] [Abstract][Full Text] [Related]
37. Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
J Clin Endocrinol Metab; 2015 Feb; 100(2):E253-61. PubMed ID: 25389633
[TBL] [Abstract][Full Text] [Related]
38. BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.
Wang CY; Guo ST; Croft A; Yan XG; Jin L; Zhang XD; Jiang CC
Mol Carcinog; 2018 Feb; 57(2):284-294. PubMed ID: 29068469
[TBL] [Abstract][Full Text] [Related]
39. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
40. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
